InterMune Inc (ITMN) Acquired in $8.3 Billion Deal

Swiss Pharmaceutical giant Roche Holding AG announced plans Sunday to buy San Francisco-based firm InterMune Inc (ITMN) for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. The Swiss drugmaker will pay $74.00 a share for InterMune, representing a premium of 38% to the stock’s closing price-per-share on Friday, August […] View the full post at: InterMune Inc (ITMN) Acquired in $8.3 Billion Deal Related posts: Yahoo – Google Deal To Be Investigated CIT Group Cuts Deal with Key Bondholders to Avoid Bankruptcy Microsoft talking to Facebook for a possible deal